Transcripts

First Tracks Biotherapeutics (TRAX) earnings call transcripts

Earnings call transcripts for First Tracks Biotherapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • trial results, October 12, 2026

    Management framed Cohort 1 as unexpectedly strong evidence that AMB033 protects both intestinal histology and symptoms, while stressing regulatory paths remain undecided.

    Oct 12, 2026Confident0.88